These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3537902)

  • 1. [The effect of the Ca2+ antagonist diltiazem on the respiratory function in chronic obstructive lung diseases].
    Zsamboki G; Magyar P; Miskovits G
    Orv Hetil; 1986 Aug; 127(33):2003-4, 2007-8. PubMed ID: 3537902
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of adequate therapy on the indices of external respiratory function in patients with arterial hypertension combined with obstructive lung diseases].
    Katiukhin VN; Sinitsina TM
    Ter Arkh; 1990; 62(3):75-8. PubMed ID: 2368003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of diltiazem on ventilation in healthy subjects and patients with chronic obstructive pulmonary disease].
    Zeng GB; Duan SF; Zhang ZX
    Zhonghua Nei Ke Za Zhi; 1988 Sep; 27(9):548-50, 587. PubMed ID: 3229193
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
    Melillo G; D'Amato G; Cocco G
    Minerva Med; 1976 Mar; 67(15):964-8. PubMed ID: 1264368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies of the effects of nifedipine, verapamil and diltiazem on respiratory mechanics in patients with atopic and non-atopic asthma].
    Wasek Z; Frank-Piskorska A; Malinowski R
    Pol Tyg Lek; 1988 Oct 17-24; 43(42-43):1358-60. PubMed ID: 3075277
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the therapeutic activity of aminosidine, in inhalational administration, in chronic obstructive bronchopneumopathies].
    Del Bufalo C; Pajello M; Cavalli A; Fabbri M; Gunella G
    G Clin Med; 1979 Dec; 60(12):991-1009. PubMed ID: 540676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the effects of salbutamol in chronic obstructive bronchopneumopathies].
    Camerota G; Pontiggia P; Curti PC
    Minerva Med; 1976 Mar; 67(16):1025-6. PubMed ID: 1264376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a new bronchiolytic preparation terbutaline in the treatment of patients with obstructive lung diseases].
    Adylova NA
    Ter Arkh; 1974; 46(5):122-5. PubMed ID: 4610870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute and chronic respiratory effects of an alpha-beta antagonist with antihypertensive action].
    Turco P; Dal Negro R
    Clin Ter; 1980 Jun; 93(6):649-55. PubMed ID: 7428320
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials of a new preparation in chronic bronchopneumopathies].
    Zuccali G; Gherson G; Parenti M
    Minerva Med; 1981 Feb; 72(7):451-8. PubMed ID: 7017497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a metoprolol-chlorthalidone combination on arterial pressure and respiratory function].
    Dolce E; Misceo N; Pirrelli A
    Cardiologia; 1983 Jan; 28(1):5-14. PubMed ID: 6686937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical-experimental testing of the effects of a new hypnotic on respiratory function in healthy subjects and in patients with chronic-obstructive syndrome].
    Mühlberger F
    Schweiz Rundsch Med Prax; 1992 Jun; 81(25):838-40. PubMed ID: 1439406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of terbutaline and glyceryl guaiacolate in chronic obstructive lung disease.
    Kokkola K; Vaara J
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):397-404. PubMed ID: 817870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardioselective beta-blocking agents and respiratory function].
    Dolce E; Misceo N; Partipilo N; Pirrelli A
    Boll Soc Ital Cardiol; 1980; 25(2):187-91. PubMed ID: 6112996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-functional observations on the use of guacetisal in the treatment of chronic obstructive bronchopneumopathy].
    Lappa B; Di Caterina N; Perna A; Di Fraia C; Verdoliva A; Margarita A
    Minerva Med; 1981 Feb; 72(7):387-92. PubMed ID: 7017489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy in chronic obstructive lung disease complicated by pulmonary hypertension and cor pulmonale: report of a case.
    D'Alonzo GE; Crevey BJ; Dantzker DR
    J Am Osteopath Assoc; 1983 Jun; 82(10):760-3. PubMed ID: 6874441
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a new beta-stimulator (Th 1165a, parahydroxyphenylorciprenaline) on the pulmonary function in chronic obstruction].
    Grabner H; Koller H; Kummer F
    Wien Z Inn Med; 1972; 53(12):639-45. PubMed ID: 4671749
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hexoprenaline on respiratory and heart functions in chronic obstructive lung disease].
    Cholevas M; Economidis D; Lefkos N; Sakamadis G; Concouris L
    Wien Med Wochenschr Suppl; 1978; 50():1-7. PubMed ID: 280024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.